Mitchell E. Hughes
Impact in
-
- Nosocomial Infections in ICU
-
- CAR-T cell therapy research
Papers in
- Oncology 16
- CAR-T cell therapy research 9
- Viral-associated cancers and disorders 3
-
- Lymphoma Diagnosis and Treatment 12
- Co-authors
- Clyde M. Ofner (1 shared paper)Sunita D. Nasta (18 shared papers)Daniel J. Landsburg (15 shared papers)Jakub Svoboda (17 shared papers)Noelle V. Frey (8 shared papers)Stephen J. Schuster (16 shared papers)Craig W. Freyer (5 shared papers)David Porter (4 shared papers)
- Journals
- Blood (10 papers)Hematological Oncology (4 papers)Clinical Infectious Diseases (1 paper)Molecular Pharmaceutics (1 paper)Blood Advances (1 paper)
- Partner nations
- United States
In The Last Decade
Mitchell E. Hughes
29 papers receiving 282 citations
Peers
Comparison fields: 5 of 76
- Critical Care and Intensive Care Medicine 25
- Oncology 103
- Infectious Diseases 61
- Pathology and Forensic Medicine 54
- Biomaterials 36
Countries citing papers authored by Mitchell E. Hughes
This map shows the geographic impact of Mitchell E. Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Hughes more than expected).
Fields of papers citing papers by Mitchell E. Hughes
This network shows the impact of papers produced by Mitchell E. Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Hughes. The network helps show where Mitchell E. Hughes may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell E. Hughes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 77 | |
| 2 | 2018 | 57 | |
| 3 | 2019 | 15 | |
| 4 | 2019 | 13 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 10 | |
| 7 | 2019 | 10 | |
| 8 | 2019 | 9 | |
| 9 | 2019 | 9 | |
| 10 | 2017 | 7 | |
| 11 | 2019 | 7 | |
| 12 | 2023 | 6 | |
| 13 | 2018 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 5 | |
| 17 | 2016 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2023 | 2 |
About Mitchell E. Hughes
Mitchell E. Hughes is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Immunology and Infectious Diseases, having authored 31 papers that have together received 284 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers), CAR-T cell therapy research (9 papers), Acute Lymphoblastic Leukemia research (3 papers), Viral-associated cancers and disorders (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Economic and Financial Impacts of Cancer (2 papers) and Intensive Care Unit Cognitive Disorders (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (25 citations), Oncology (103 citations), Infectious Diseases (61 citations), Pathology and Forensic Medicine (54 citations) and Biomaterials (36 citations). Mitchell E. Hughes has collaborated with scholars based in United States. Frequent co-authors include Clyde M. Ofner, Sunita D. Nasta, Daniel J. Landsburg, Jakub Svoboda, Noelle V. Frey, Stephen J. Schuster, Craig W. Freyer, David Porter, James N. Gerson and Elizabeth O. Hexner. Their work appears in journals such as Blood, Hematological Oncology, Clinical Infectious Diseases, Molecular Pharmaceutics and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.